Profile
Keith R.
Bley worked as a Research Manager in the Analgesia Department at Syntex Corp.
and Roche Palo Alto LLC from 1991 to 2000.
He then worked as Senior Vice President of Product Development at NovaBay Pharmaceuticals, Inc. and later as SVP of Nonclinical Research & Development at NeurogesX, Inc. Dr. Bley holds an undergraduate degree from The Catholic University of America, a graduate degree from The Trustees of Columbia University in The City of New York, and a doctorate from Yale University, which was conferred in 2010.
Former positions of Keith R. Bley
Companies | Position | End |
---|---|---|
Roche Palo Alto LLC
Roche Palo Alto LLC Pharmaceuticals: MajorHealth Technology Roche Palo Alto LLC discovers and develops medicines. Its medicines are used for the treatment of central nervous system, inflammation, metabolism, oncology, and virology diseases. The company was founded in 1961 and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | 2000-01-09 |
Syntex Corp. | Corporate Officer/Principal | 1999-12-31 |
NOVABAY PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
NEUROGESX, INC | Chief Tech/Sci/R&D Officer | - |
Training of Keith R. Bley
The Trustees of Columbia University in The City of New York | Graduate Degree |
Yale University | Doctorate Degree |
The Catholic University of America | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
NOVABAY PHARMACEUTICALS, INC. | Health Technology |
Private companies | 3 |
---|---|
NeurogesX, Inc.
NeurogesX, Inc. Pharmaceuticals: MajorHealth Technology NeurogesX, Inc. developed and commercialized novel pain management therapies. The company was founded by Wendye R. Robbins on May 28, 1998 and was headquartered in San Mateo, CA. | Health Technology |
Roche Palo Alto LLC
Roche Palo Alto LLC Pharmaceuticals: MajorHealth Technology Roche Palo Alto LLC discovers and develops medicines. Its medicines are used for the treatment of central nervous system, inflammation, metabolism, oncology, and virology diseases. The company was founded in 1961 and is headquartered in Palo Alto, CA. | Health Technology |
Syntex Corp. | Health Technology |
- Stock Market
- Insiders
- Keith R. Bley